Søgeresultater - Osamu Miura
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM af Daisuke Watanabe, Ayako Nogami, Keigo Okada, Hiroki Akiyama, Yoshihiro Umezawa, Osamu Miura
Udgivet 2019Artigo -
10
-
11
-
12
-
13
-
14
FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia af Ayako Nogami, Gaku Oshikawa, Keigo Okada, Shusaku Fukutake, Yoshihiro Umezawa, Toshikage Nagao, Tetsuya Kurosu, Osamu Miura
Udgivet 2015Artigo -
15
-
16
High‐dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphoma af Hiroki Akiyama, Hiroshi Takase, Fumito Kubo, Tohru Miki, Masahide Yamamoto, Makoto Tomita, Manabu Mochizuki, Osamu Miura, Ayako Arai
Udgivet 2016Artigo -
17
-
18
-
19
STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target af Erika Onozawa, Haruna Shibayama, Honami Takada, Ken‐Ichi Imadome, Sho Aoki, Mayumi Yoshimori, Norio Shimizu, Shigeyoshi Fujiwara, Takatoshi Koyama, Osamu Miura, Ayako Arai
Udgivet 2018Artigo -
20
EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells af Honami Takada, Ken‐Ichi Imadome, Haruna Shibayama, Mayumi Yoshimori, Ludan Wang, Yasunori Saitoh, Shin Uota, Shoji Yamaoka, Takatoshi Koyama, Norio Shimizu, Kouhei Yamamoto, Shigeyoshi Fujiwara, Osamu Miura, Ayako Arai
Udgivet 2017Artigo
Søgeredskaber:
Relaterede emner
Biology
Biochemistry
Cell biology
Phosphorylation
Receptor
Erythropoietin receptor
Molecular biology
Signal transduction
Receptor tyrosine kinase
Tyrosine phosphorylation
Cancer research
Chemistry
Tyrosine
Tyrosine kinase
Endocrinology
Erythropoietin
Medicine
Protein tyrosine phosphatase
Internal medicine
Lymphoma
SH2 domain
Apoptosis
Gene
Immunology
Janus kinase 2
Kinase
Proto-oncogene tyrosine-protein kinase Src
STAT5
Adverse effect
Chemotherapy